Glenmark confirms patent challenge for Bendamustine Hydrochloride
This ANDA has been filed from Glenmark's Argentina lyophilized injectable facility
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
BIOINVEST 2014 to be held in Mumbai
To explore opportunities for investment in the biotech sector for the next five years
US FDA approves Tretten to treat rare genetic clotting disorder
Tretten is a recombinant analogue of the human Factor XIII A-subunit that is produced in yeast cells and then further purified
FDA and European Medicines Agency announce generic-drug application inspections initiative
The initiative creates a process to conduct joint facility inspections for generic-drug applications submitted to both agencies
CHMP recommends EU approval of Piramal Imaging’s NeuraCeq
NeuraCeq is a radio pharmaceutical indicated for Positron Emission Tomography (PET) imaging of neuritic beta-amyloid plaque…
Scientific sessions raise and discuss pertinent issues, job fair a hit
The second day of the 65th IPC saw increased participation by students in the pharma job fair as well as delegates in the…